Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Senjabio AS
AS
Active
Org 994340360
Husøy, 9389
Husøy I Senja
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2009 · 16 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Senjabio AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
KK
Karl Kristian Eilertsen
Deputy Member
Deputy Member
2026
KJ
Kato Johansen
Deputy Member
Deputy Member
2020
Former (1)
EJ
Egil Johansen
Deputy Member
Deputy Member
2020 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
KO
Knut Otto Johnsen
Board of Directors
Board of Directors
2020
RP
Randi Paula Karlsen
Chairman
Chairman
2020
EJ
Egil Johansen
Board of Directors
Board of Directors
2026
Former (2)
AH
Arne Hugo Hanssen
Board of Directors
Board of Directors
2020 – 2023
ØU
Ørjan Uteng Berntsen
Board of Directors
Board of Directors
2023 – 2026
Shareholders
As of last annual report
Statthansa As — 15.56%
Mikkelsplass Invest As — 15.56%
Karl Kristian Eilertsen — 11.11%
BR. KARLSEN EIENDOM AS — 11.11%
Frewi As — 10%
Knut Otto Johnsen — 10%
Kjempa Holding As — 8.89%
Silsand Maskin As — 8.89%
Arne Hugo Hanssen — 8.89%
100%
Shareholder
Type
Ownership
Votes
Since
Statthansa As
Company
15.56%
15.56%
2025
Mikkelsplass Invest As
Company
15.56%
15.56%
2025
Karl Kristian Eilertsen
Individual
11.11%
11.11%
2025
BR. KARLSEN EIENDOM AS
Company
11.11%
11.11%
2025
Frewi As
Company
10%
10%
2025
Knut Otto Johnsen
Individual
10%
10%
2025
Kjempa Holding As
Company
8.89%
8.89%
2025
Silsand Maskin As
Company
8.89%
8.89%
2025
Arne Hugo Hanssen
Individual
8.89%
8.89%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Senjabio AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network